Key facts
- This page summarizes Lisa Wright's Form 4 filing for Vericel Corp (VCEL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jun 2024, 16:05.
Lisa Wright - 03 Jun 2024 Form 4 Insider Report for Vericel Corp (VCEL)
- Reporting relationship
- Director
- Issuer ticker
- VCEL
- Reported as of
- 03 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Jun 2024, 16:05:33 UTC
- Prior SEC filing
- 03 May 2024
- Next SEC filing
- 02 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sean Flynn, as Attorney-in-Fact for Lisa Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Lisa Wright filed Form 4 for Vericel Corp (VCEL) on 05 Jun 2024.
Change
- Previous filing in this sequence was filed on 03 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VCEL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +434
- Change %
- +4.8%
- Price
- Shares after
- 9,451
- Date
- 03 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VCEL
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- +434
- Change %
- Price
- $0.000000*
- Shares after
- 0
- Date
- 03 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 434
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021.
Footnote F2
Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
Footnote F3
These RSUs vest in equal annual installments over three years, beginning on June 1, 2021.
Footnote F4
No expiration date for this type of award.